• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA-574-5p 通过靶向 HOXC6 表达抑制肝细胞脂质摄取以减轻非酒精性脂肪肝疾病。

MicroRNA-574-5p targeting HOXC6 expression inhibits the hepatocyte lipid uptake to alleviate non-alcoholic fatty liver disease.

机构信息

College of Life Sciences and Health, Northeastern University, Shenyang, 110169, China; Department of Cardiology and Cardiovascular Research Institute of PLA, General Hospital of Northern Theater Command, Shenyang, 110016, China.

Department of Cardiology and Cardiovascular Research Institute of PLA, General Hospital of Northern Theater Command, Shenyang, 110016, China.

出版信息

Exp Cell Res. 2023 Jul 1;428(1):113631. doi: 10.1016/j.yexcr.2023.113631. Epub 2023 May 5.

DOI:10.1016/j.yexcr.2023.113631
PMID:37150392
Abstract

Non-alcoholic fatty liver disease (NAFLD) is one of the main causes of liver disease that has reached its last stage. Over the past few years, evidence for miRNAs' centrality in NAFLD pathogenesis has accumulated. According to some studies, miR-574-5p plays a role in lipid metabolism. However, research on the relationship between miR-574-5p and NAFLD is lacking. For in vivo experiments, we induced the NAFLD mice model with a high-fat diet (HFD). AgomiR-574-5p was injected intravenously into HFD-fed mice for eight weeks, and qPCR was used to identify the expression of miR-574-5p in the serum. In in vitro experiments, The treatment of L-O2 cells with a miR-574-5p mimic resulted in a significant reduction in lipid deposition, suggesting that miR-574-5p can inhibit lipid accumulation and lipid formation induced by OA. The dual-luciferase reporter gene assay revealed that miR-574-5p targets the 3' UTR region of HOXC6 directly. We discovered that OA-induced lipid accumulation in hepatocytes might be mediated through the miR-574-5p-HOXC6 signaling axis. Additional research is required in order to determine the specific mechanism by which HOXC6 downstream pathways are involved in the miR-574-5p induced lipid uptake.

摘要

非酒精性脂肪性肝病 (NAFLD) 是一种终末期肝病的主要病因。近年来,miRNA 在 NAFLD 发病机制中的核心作用的证据不断积累。一些研究表明,miR-574-5p 在脂质代谢中发挥作用。然而,关于 miR-574-5p 与 NAFLD 的关系的研究还很缺乏。对于体内实验,我们用高脂肪饮食(HFD)诱导 NAFLD 小鼠模型。用 agomiR-574-5p 静脉注射 HFD 喂养的小鼠 8 周,并用 qPCR 鉴定血清中 miR-574-5p 的表达。在体外实验中,miR-574-5p 模拟物处理 L-O2 细胞导致脂质沉积明显减少,表明 miR-574-5p 可以抑制 OA 诱导的脂质积累和脂质形成。双荧光素酶报告基因检测显示,miR-574-5p 直接靶向 HOXC6 的 3'UTR 区域。我们发现,OA 诱导的肝细胞脂质积累可能是通过 miR-574-5p-HOXC6 信号轴介导的。需要进一步研究以确定 HOXC6 下游途径参与 miR-574-5p 诱导的脂质摄取的具体机制。

相似文献

1
MicroRNA-574-5p targeting HOXC6 expression inhibits the hepatocyte lipid uptake to alleviate non-alcoholic fatty liver disease.miRNA-574-5p 通过靶向 HOXC6 表达抑制肝细胞脂质摄取以减轻非酒精性脂肪肝疾病。
Exp Cell Res. 2023 Jul 1;428(1):113631. doi: 10.1016/j.yexcr.2023.113631. Epub 2023 May 5.
2
miR-218-5p promotes hepatic lipogenesis through targeting Elovl5 in non-alcoholic fatty liver disease.miR-218-5p 通过靶向 Elovl5 促进非酒精性脂肪性肝病中的肝脂肪生成。
Biochem Pharmacol. 2024 Aug;226:116411. doi: 10.1016/j.bcp.2024.116411. Epub 2024 Jul 5.
3
Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.下调 microRNA-130b-5p 可预防非酒精性脂肪性肝病小鼠模型中的脂质积累和胰岛素抵抗。
Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E34-E42. doi: 10.1152/ajpendo.00528.2019. Epub 2020 Mar 31.
4
MicroRNA-376b-3p ameliorates nonalcoholic fatty liver disease by targeting FGFR1 and regulating lipid oxidation in hepatocytes.微小 RNA-376b-3p 通过靶向 FGFR1 并调节肝细胞内脂质氧化改善非酒精性脂肪性肝病。
Life Sci. 2022 Nov 1;308:120925. doi: 10.1016/j.lfs.2022.120925. Epub 2022 Aug 31.
5
miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1.miR-192-5p 通过 SCD-1 调节非酒精性脂肪性肝病中的脂质合成。
World J Gastroenterol. 2017 Dec 14;23(46):8140-8151. doi: 10.3748/wjg.v23.i46.8140.
6
miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis.miR-32-5p 通过触发从头合成脂质来诱导肝脂肪变性和高血脂。
Metabolism. 2023 Sep;146:155660. doi: 10.1016/j.metabol.2023.155660. Epub 2023 Jul 13.
7
miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.miR-122 通过靶向 Sirt1 抑制 LKB1/AMPK 通路促进非酒精性脂肪性肝病中的肝脂肪生成。
Mol Med. 2019 Jun 13;25(1):26. doi: 10.1186/s10020-019-0085-2.
8
Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression.人脐带间充质干细胞来源的细胞外囊泡 miR-627-5p 通过抑制 FTO 表达改善非酒精性脂肪性肝病。
Hum Cell. 2021 Nov;34(6):1697-1708. doi: 10.1007/s13577-021-00593-1. Epub 2021 Aug 19.
9
Uric acid induced hepatocytes lipid accumulation through regulation of miR-149-5p/FGF21 axis.尿酸通过调节 miR-149-5p/FGF21 轴诱导肝细胞脂质积累。
BMC Gastroenterol. 2020 Feb 18;20(1):39. doi: 10.1186/s12876-020-01189-z.
10
Inhibiting miR-27a and miR-142-5p attenuate nonalcoholic fatty liver disease by regulating Nrf2 signaling pathway.抑制 miR-27a 和 miR-142-5p 通过调控 Nrf2 信号通路减轻非酒精性脂肪性肝病。
IUBMB Life. 2020 Mar;72(3):361-372. doi: 10.1002/iub.2221. Epub 2019 Dec 30.

引用本文的文献

1
miR-574-5p in epigenetic regulation and Toll-like receptor signaling.miR-574-5p 在表观遗传调控和 Toll 样受体信号通路中的作用。
Cell Commun Signal. 2024 Nov 26;22(1):567. doi: 10.1186/s12964-024-01934-x.
2
Unraveling the molecular links between benzopyrene exposure, NASH, and HCC: an integrated bioinformatics and experimental study.揭示苯并芘暴露、NASH 和 HCC 之间的分子联系:一项综合生物信息学和实验研究。
Sci Rep. 2023 Nov 22;13(1):20520. doi: 10.1038/s41598-023-46440-1.